VEGF and Age-related Macular Degeneration

Ophthalmology

Volumn 116, Issue 6, 2009, Pages

  McKay, Gareth J ^a   Silvestri, Giuliana ^a   Orr, Nick ^a   Chakravarthy, Usha ^a   Hughes, Anne E ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT FACTOR H; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN INHIBITOR;

CONTROLLED STUDY; EYE INJURY; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINAL ANGIOMATOUS PROLIFERATION LESION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 66049163541     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.01.008     Document Type: Letter

References (5)

1. Haines J.L., Schnetz-Boutaud N., Schmidt S., et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 47 (2006) 329-335
2. Churchill A.J., Carter J.G., Lovell H.C., et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 15 (2006) 2955-2961
3. Francis P.J., Hamon S.C., Ott J., et al. Polymorphisms in C2, CFB and C3 are associated with progression to Advanced Age-Related Macular Degeneration associated with visual loss. J Med Genet (2008) Nov 17. [Epub ahead of print]
4. Richardson A.J., Islam F.M., Guymer R.H., et al. A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. Mol Vis 13 (2007) 2148-2152
5. Meyerle C.B., Freund K.B., Iturralde D., et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27 (2007) 451-457